Wright's Dental Lab
Financial Plan
The following is the financial plan for Wright’s Dental Laboratory.
Start-up Funding
Each of the two Wright’s, David and Charles, will invest in the venture. An additional long-term loan will be secured from the SBA, or local lenders, with an interest rate not more that 10%.
| Start-up Funding | |
| Start-up Expenses to Fund | $76,300 |
| Start-up Assets to Fund | $173,700 |
| Total Funding Required | $250,000 |
| Assets | |
| Non-cash Assets from Start-up | $102,000 |
| Cash Requirements from Start-up | $71,700 |
| Additional Cash Raised | $0 |
| Cash Balance on Starting Date | $71,700 |
| Total Assets | $173,700 |
| Liabilities and Capital | |
| Liabilities | |
| Current Borrowing | $0 |
| Long-term Liabilities | $100,000 |
| Accounts Payable (Outstanding Bills) | $0 |
| Other Current Liabilities (interest-free) | $0 |
| Total Liabilities | $100,000 |
| Capital | |
| Planned Investment | |
| Charles | $75,000 |
| David | $75,000 |
| Additional Investment Requirement | $0 |
| Total Planned Investment | $150,000 |
| Loss at Start-up (Start-up Expenses) | ($76,300) |
| Total Capital | $73,700 |
| Total Capital and Liabilities | $173,700 |
| Total Funding | $250,000 |
Break-even Analysis
The following table and chart display the monthly break-even point.
| Break-even Analysis | |
| Monthly Revenue Break-even | $49,013 |
| Assumptions: | |
| Average Percent Variable Cost | 36% |
| Estimated Monthly Fixed Cost | $31,400 |
Projected Profit and Loss
The following table and charts will highlight projected profit and loss for the next three years.
| Pro Forma Profit and Loss | |||
| Year 1 | Year 2 | Year 3 | |
| Sales | $615,000 | $750,000 | $880,000 |
| Direct Cost of Sales | $221,000 | $269,250 | $315,920 |
| Other Production Expenses | $0 | $0 | $0 |
| Total Cost of Sales | $221,000 | $269,250 | $315,920 |
| Gross Margin | $394,000 | $480,750 | $564,080 |
| Gross Margin % | 64.07% | 64.10% | 64.10% |
| Expenses | |||
| Payroll | $264,000 | $290,000 | $324,000 |
| Sales and Marketing and Other Expenses | $24,000 | $30,000 | $35,000 |
| Depreciation | $12,000 | $12,000 | $12,000 |
| Leased Equipment | $0 | $0 | $0 |
| Utilities | $6,000 | $6,000 | $6,000 |
| Insurance | $7,200 | $7,200 | $7,200 |
| Rent | $24,000 | $24,000 | $24,000 |
| Payroll Taxes | $39,600 | $43,500 | $48,600 |
| Other | $0 | $0 | $0 |
| Total Operating Expenses | $376,800 | $412,700 | $456,800 |
| Profit Before Interest and Taxes | $17,200 | $68,050 | $107,280 |
| EBITDA | $29,200 | $80,050 | $119,280 |
| Interest Expense | $12,463 | $12,520 | $11,777 |
| Taxes Incurred | $1,421 | $16,659 | $28,651 |
| Net Profit | $3,316 | $38,871 | $66,852 |
| Net Profit/Sales | 0.54% | 5.18% | 7.60% |
Projected Cash Flow
The following table and chart highlight the projected cash flow for three years. It will be necessary for each Wright brother to loan the company additional funds mid-year.
| Pro Forma Cash Flow | |||
| Year 1 | Year 2 | Year 3 | |
| Cash Received | |||
| Cash from Operations | |||
| Cash Sales | $153,750 | $187,500 | $220,000 |
| Cash from Receivables | $343,250 | $536,598 | $635,057 |
| Subtotal Cash from Operations | $497,000 | $724,098 | $855,057 |
| Additional Cash Received | |||
| Sales Tax, VAT, HST/GST Received | $0 | $0 | $0 |
| New Current Borrowing | $0 | $0 | $0 |
| New Other Liabilities (interest-free) | $0 | $0 | $0 |
| New Long-term Liabilities | $40,000 | $0 | $0 |
| Sales of Other Current Assets | $0 | $0 | $0 |
| Sales of Long-term Assets | $0 | $0 | $0 |
| New Investment Received | $0 | $0 | $0 |
| Subtotal Cash Received | $537,000 | $724,098 | $855,057 |
| Expenditures | Year 1 | Year 2 | Year 3 |
| Expenditures from Operations | |||
| Cash Spending | $264,000 | $290,000 | $324,000 |
| Bill Payments | $314,168 | $418,284 | $475,335 |
| Subtotal Spent on Operations | $578,168 | $708,284 | $799,335 |
| Additional Cash Spent | |||
| Sales Tax, VAT, HST/GST Paid Out | $0 | $0 | $0 |
| Principal Repayment of Current Borrowing | $0 | $0 | $0 |
| Other Liabilities Principal Repayment | $0 | $0 | $0 |
| Long-term Liabilities Principal Repayment | $9,864 | $9,864 | $5,000 |
| Purchase Other Current Assets | $0 | $0 | $0 |
| Purchase Long-term Assets | $0 | $0 | $0 |
| Dividends | $0 | $0 | $0 |
| Subtotal Cash Spent | $588,032 | $718,148 | $804,335 |
| Net Cash Flow | ($51,032) | $5,950 | $50,722 |
| Cash Balance | $20,668 | $26,618 | $77,340 |
Projected Balance Sheet
The following table highlights the projected balance sheet for three years.
| Pro Forma Balance Sheet | |||
| Year 1 | Year 2 | Year 3 | |
| Assets | |||
| Current Assets | |||
| Cash | $20,668 | $26,618 | $77,340 |
| Accounts Receivable | $118,000 | $143,902 | $168,846 |
| Inventory | $30,800 | $31,307 | $35,377 |
| Other Current Assets | $12,000 | $12,000 | $12,000 |
| Total Current Assets | $181,468 | $213,827 | $293,562 |
| Long-term Assets | |||
| Long-term Assets | $80,000 | $80,000 | $80,000 |
| Accumulated Depreciation | $12,000 | $24,000 | $36,000 |
| Total Long-term Assets | $68,000 | $56,000 | $44,000 |
| Total Assets | $249,468 | $269,827 | $337,562 |
| Liabilities and Capital | Year 1 | Year 2 | Year 3 |
| Current Liabilities | |||
| Accounts Payable | $42,317 | $33,669 | $39,552 |
| Current Borrowing | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 |
| Subtotal Current Liabilities | $42,317 | $33,669 | $39,552 |
| Long-term Liabilities | $130,136 | $120,272 | $115,272 |
| Total Liabilities | $172,453 | $153,941 | $154,824 |
| Paid-in Capital | $150,000 | $150,000 | $150,000 |
| Retained Earnings | ($76,300) | ($72,984) | ($34,114) |
| Earnings | $3,316 | $38,871 | $66,852 |
| Total Capital | $77,016 | $115,886 | $182,738 |
| Total Liabilities and Capital | $249,468 | $269,827 | $337,562 |
| Net Worth | $77,016 | $115,886 | $182,738 |
Business Ratios
Business ratios for the years of this plan are shown below. Industry profile ratios based on the Standard Industrial Classification (SIC) code 8072, Dental Laboratories, are shown for comparison.
| Ratio Analysis | ||||
| Year 1 | Year 2 | Year 3 | Industry Profile | |
| Sales Growth | n.a. | 21.95% | 17.33% | 6.60% |
| Percent of Total Assets | ||||
| Accounts Receivable | 47.30% | 53.33% | 50.02% | 15.10% |
| Inventory | 12.35% | 11.60% | 10.48% | 4.50% |
| Other Current Assets | 4.81% | 4.45% | 3.55% | 56.00% |
| Total Current Assets | 72.74% | 79.25% | 86.97% | 75.60% |
| Long-term Assets | 27.26% | 20.75% | 13.03% | 24.40% |
| Total Assets | 100.00% | 100.00% | 100.00% | 100.00% |
| Current Liabilities | 16.96% | 12.48% | 11.72% | 34.20% |
| Long-term Liabilities | 52.17% | 44.57% | 34.15% | 18.20% |
| Total Liabilities | 69.13% | 57.05% | 45.87% | 52.40% |
| Net Worth | 30.87% | 42.95% | 54.13% | 47.60% |
| Percent of Sales | ||||
| Sales | 100.00% | 100.00% | 100.00% | 100.00% |
| Gross Margin | 64.07% | 64.10% | 64.10% | 0.00% |
| Selling, General & Administrative Expenses | 63.37% | 58.73% | 56.34% | 70.40% |
| Advertising Expenses | 3.90% | 4.00% | 3.98% | 0.20% |
| Profit Before Interest and Taxes | 2.80% | 9.07% | 12.19% | 10.10% |
| Main Ratios | ||||
| Current | 4.29 | 6.35 | 7.42 | 1.81 |
| Quick | 3.56 | 5.42 | 6.53 | 1.25 |
| Total Debt to Total Assets | 69.13% | 57.05% | 45.87% | 52.40% |
| Pre-tax Return on Net Worth | 6.15% | 47.92% | 52.26% | 18.10% |
| Pre-tax Return on Assets | 1.90% | 20.58% | 28.29% | 38.00% |
| Additional Ratios | Year 1 | Year 2 | Year 3 | |
| Net Profit Margin | 0.54% | 5.18% | 7.60% | n.a |
| Return on Equity | 4.31% | 33.54% | 36.58% | n.a |
| Activity Ratios | ||||
| Accounts Receivable Turnover | 3.91 | 3.91 | 3.91 | n.a |
| Collection Days | 56 | 85 | 86 | n.a |
| Inventory Turnover | 10.48 | 8.67 | 9.48 | n.a |
| Accounts Payable Turnover | 8.42 | 12.17 | 12.17 | n.a |
| Payment Days | 28 | 34 | 28 | n.a |
| Total Asset Turnover | 2.47 | 2.78 | 2.61 | n.a |
| Debt Ratios | ||||
| Debt to Net Worth | 2.24 | 1.33 | 0.85 | n.a |
| Current Liab. to Liab. | 0.25 | 0.22 | 0.26 | n.a |
| Liquidity Ratios | ||||
| Net Working Capital | $139,152 | $180,158 | $254,010 | n.a |
| Interest Coverage | 1.38 | 5.44 | 9.11 | n.a |
| Additional Ratios | ||||
| Assets to Sales | 0.41 | 0.36 | 0.38 | n.a |
| Current Debt/Total Assets | 17% | 12% | 12% | n.a |
| Acid Test | 0.77 | 1.15 | 2.26 | n.a |
| Sales/Net Worth | 7.99 | 6.47 | 4.82 | n.a |
| Dividend Payout | 0.00 | 0.00 | 0.00 | n.a |
By 
